UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 145

Sortiert nach

Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (43), p.E2939-E2948

2012

Volltextzugriff (PDF)

Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer

eLife, 2017-10, Vol.6

2017

Volltextzugriff (PDF)

Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia

PloS one, 2022-12, Vol.17 (12), p.e0277892-e0277892

2022

Volltextzugriff (PDF)

Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes

PloS one, 2013-11, Vol.8 (11), p.e80314-e80314

2013

Volltextzugriff (PDF)

Whole Genome Oligonucleotide-Based Array Comparative Genomic Hybridization Analysis Identified Fibroblast Growth Factor 1 As a Prognostic Marker for Advanced-Stage Serous Ovarian Adenocarcinomas

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2281-2287

2007

Volltextzugriff (PDF)

Gestational trophoblastic neoplasia: one size does not fit all – Authors' reply

The lancet oncology, 2021-10, Vol.22 (10), p.e421-e421

2021

Volltextzugriff (PDF)

Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma

Oncogene, 2022-06, Vol.41 (26), p.3510-3510

2022

Volltextzugriff (PDF)

Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer

Scientific reports, 2020-11, Vol.10 (1), p.20071, Article 20071

2020

Volltextzugriff (PDF)

Pinin interacts with C-terminal binding proteins for RNA alternative splicing and epithelial cell identity of human ovarian cancer cells

Oncotarget, 2016-03, Vol.7 (10), p.11397-11411

2016

Volltextzugriff (PDF)

Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer

Annals of surgical oncology, 2015-12, Vol.22 (Suppl 3), p.1606-1607

2015

Volltextzugriff (PDF)

Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer

Annals of surgical oncology, 2015-12, Vol.22 (Suppl 3), p.1611-1611

2015

Volltextzugriff (PDF)

Current Chemotherapeutic Management of Patients with Gestational Trophoblastic Neoplasia

Chemotherapy Research and Practice, 2011-01, Vol.2011, p.806256-12

2011

Volltextzugriff (PDF)

The endoglin–BMP9 axis as a predictor of methotrexate resistance in low-risk gestational trophoblastic neoplasia

Gynecologic oncology, 2015-02, Vol.136 (2), p.407-407

2015

Volltextzugriff (PDF)

Safety of same day discharge in patients undergoing laparoscopic hysterectomy for endometrial intraepithelial neoplasia (EIN) and malignancy

Gynecologic oncology, 2015-02, Vol.136 (2), p.405-406

2015

Volltextzugriff (PDF)

Correction: Pinin interacts with C-terminal binding proteins for RNA alternative splicing and epithelial cell identity of human ovarian cancer cells

Oncotarget, 2017-02, Vol.8 (7), p.12533-12533

2017

Volltextzugriff (PDF)

Chorionic Tumors

The New England journal of medicine, 1996-12, Vol.335 (23), p.1740-1748

1996

Volltextzugriff (PDF)

Gestational Trophoblastic Disease

Clinical obstetrics and gynecology, 2007-03, Vol.50 (1), p.112-122

2007

Volltextzugriff (PDF)

Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia

PloS one, 2022-12, Vol.17 (12), p.e0277892

2022

Volltextzugriff (PDF)

Abstract MIP-052: THE ROLES OF CD24 IN OVARIAN CANCER DEVELOPMENT

Clinical cancer research, 2017-06, Vol.23 (11_Supplement), p.MIP-052-MIP-052

2017

Volltextzugriff (PDF)

Abstract PR06: Dissecting mechanisms of replication fork stabilization in patient-derived high-grade serous organoid cultures and their impact on therapeutic sensitivity and the immune-tumor interaction

Clinical cancer research, 2020-07, Vol.26 (13_Supplement), p.PR06-PR06

2020

Volltextzugriff (PDF)

Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies

Gynecologic oncology, 2004-06, Vol.93 (3), p.702-707

2004

Volltextzugriff (PDF)

Abstract PR09: Derivation and validation of a serum diagnostic test for ovarian cancer using miRNA-seq

Clinical cancer research, 2018-08, Vol.24 (15_Supplement), p.PR09-PR09

2018

Volltextzugriff (PDF)

In Reply

Obstetrics and gynecology (New York. 1953), 2018-07, Vol.132 (1), p.218-218

2018

Volltextzugriff (PDF)

In Reply

Obstetrics and gynecology (New York. 1953), 2018-07, Vol.132 (1), p.218-218

2018

Volltextzugriff (PDF)

Abstract AP10: REAL-TIME ASSESSMENT OF HGSC DNA DAMAGE REPAIR DEFECTS AND DEFECT-INDUCED RESPONSE TO THERAPY IN OVARIAN CANCER ORGANOIDS

Clinical cancer research, 2019-11, Vol.25 (22_Supplement), p.AP10-AP10

2019

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(35)
Female
(29)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Pregnancy
(14)
Adult
(11)
Tumors
(11)
Gynecology. Andrology. Obstetrics
(10)
Middle Aged
(10)
Science & Technology
(10)
Adolescent
(7)
Ovarian Neoplasms - Pathology
(7)
Chemotherapy
(6)
Ovarian Cancer
(6)
Ovarian Neoplasms - Genetics
(6)
Diseases Of Mother, Fetus And Pregnancy
(5)
Female Genital Diseases
(5)
Hematology, Oncology And Palliative Medicine
(5)
Multidisciplinary Sciences
(5)
Pregnancy. Fetus. Placenta
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy

Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer

Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia

Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes

Whole Genome Oligonucleotide-Based Array Comparative Genomic Hybridization Analysis Identified Fibroblast Growth Factor 1 As a Prognostic Marker for Advanced-Stage Serous Ovarian Adenocarcinomas

Gestational trophoblastic neoplasia: one size does not fit all – Authors' reply

Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma

Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer

Pinin interacts with C-terminal binding proteins for RNA alternative splicing and epithelial cell identity of human ovarian cancer cells

Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer

Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer

Current Chemotherapeutic Management of Patients with Gestational Trophoblastic Neoplasia

The endoglin–BMP9 axis as a predictor of methotrexate resistance in low-risk gestational trophoblastic neoplasia

Safety of same day discharge in patients undergoing laparoscopic hysterectomy for endometrial intraepithelial neoplasia (EIN) and malignancy

Correction: Pinin interacts with C-terminal binding proteins for RNA alternative splicing and epithelial cell identity of human ovarian cancer cells

Chorionic Tumors

Gestational Trophoblastic Disease

Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia

Abstract MIP-052: THE ROLES OF CD24 IN OVARIAN CANCER DEVELOPMENT

Abstract PR06: Dissecting mechanisms of replication fork stabilization in patient-derived high-grade serous organoid cultures and their impact on therapeutic sensitivity and the immune-tumor interaction

Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies

Abstract PR09: Derivation and validation of a serum diagnostic test for ovarian cancer using miRNA-seq

In Reply

In Reply

Abstract AP10: REAL-TIME ASSESSMENT OF HGSC DNA DAMAGE REPAIR DEFECTS AND DEFECT-INDUCED RESPONSE TO THERAPY IN OVARIAN CANCER ORGANOIDS

Aktive Filter

Suchergebnisse filtern